Related Experiment Videos
Diagnostic tests for fragile X syndrome
1Dept. Clinical Genetics, Erasmus University, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. Oostra@kgen.fgg.eur.nl
Expert Review of Molecular Diagnostics
|March 21, 2002
Summary
Fragile X syndrome, a genetic disorder, is often caused by FMR1 gene mutations. New PCR and antibody tests offer improved prenatal and postnatal diagnosis for this common X-linked intellectual disability.
Area of Science:
- Genetics
- Molecular Biology
- Medical Diagnostics
Background:
- Fragile X syndrome is a common X-linked hereditary disease causing intellectual disability.
- It is typically caused by a deficit or absence of the FMR1 protein.
- CGG repeat expansion in the FMR1 gene is the primary genetic cause.
Purpose of the Study:
- To review current DNA-based diagnostic methods for Fragile X syndrome.
- To highlight newly developed PCR and immunocytochemical antibody methods.
- To discuss the application of these methods in prenatal and postnatal diagnosis.
Main Methods:
- Review of established DNA diagnostic techniques including PCR amplification and Southern blotting.
- Analysis of immunocytochemical tests utilizing monoclonal antibodies for FMR1 protein detection.
- Evaluation of newly developed PCR and antibody-based diagnostic approaches.
Main Results:
- Traditional DNA methods like PCR and Southern blotting are standard diagnostic tools.
- Immunocytochemical tests offer an alternative by detecting FMR1 protein levels.
- Newer PCR and antibody methods show promise for enhanced diagnostic accuracy.
Conclusions:
- Accurate diagnosis of Fragile X syndrome relies on detecting FMR1 gene abnormalities or protein deficits.
- Updated PCR and antibody-based methods are crucial for effective prenatal and postnatal screening.
- These advancements improve the diagnosis and management of Fragile X syndrome.